Gainers
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.
BridgeBio Pharma, Inc. (NASDAQ: BBIO) shares jumped 59.5% to $17.34 after the company announced positive data for its phase 2 study of Infigratinib in Achondroplasia.
Avalon GloboCare Corp. (NASDAQ: ALBT) shares gained 53.5% to $3.3330.
Azul S.A. (NYSE: AZUL) gained 45.3% to $6.05 after the company announced a deal to reduce the immediate cash it must expend for leased property.
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) rose 28.3% to $21.49. HC Wainwright & Co. maintained Kala Pharmaceuticals with a Buy and raised the price target from $12 to $20.Kala Pharmaceuticals recently said Q4 adjusted EPS results were higher year over year.
TCR2 Therapeutics Inc. (NASDAQ: TCRR) gained 28% to $1.55 after the company and Adaptimmune announced a strategic combination to create a preeminent cell therapy company for solid tumors.
Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) surged 25% to $2.28. Bellerophon Therapeutics announced a $5 million registered direct offering with institutional investor.
Genius Group Limited (NYSE: GNS) gained 22.5% to $4.4493.
Entera Bio Ltd. (NASDAQ: ENTX) rose 22.1% to $1.2206 after dropping 5% on Friday. Entera Bio recently announced the FDA's acceptance of a Type D meeting review to affirm design of the pivotal, Phase 3 protocol for EB613 PTH mini tablets, as the first oral osteoanabolic treatment of post-menopausal osteoporosis.
Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) ...
Related tickers: BRQS, SNCE, SECO, EMBK, CECO, ENTX, BZFD, GOL, RUBY, SIDU, HTZ, ORTX, GNS, BCAN, UIS, TCRR, YOSH, RCON, ARMP, ALBT, ESPR, BBIO, OCS, BLCM, IAA, BLPH, ADXN, ADAP, PSHG, ACRS, DMS, OBSV, VVOS, SNAP, MSGM, AZUL, TRKA, KALA, UNCY.
Read Full Article
